Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study is an observational, multi-center, prospective, non-interventional and open-label
data collection study assessing outcomes, treatment patterns, adverse events and costs in
patients diagnosed with bullous pemphigoid. The patient enrollment period will be 1 year with
a follow-up (observation period) of 1 year for each patient. Four dermatology centres in
France will participate. The hypothesis to be answered by the study is that superpotent
topical corticosteroid therapy is properly used to treat bullous pemphigoid in real-world
life as recommended by French guidelines and whether this treatment influences the medical
costs by comparison with systemic therapies (e.g. methotrexate or prednisone).